AzTrials
AzTrials

InactivityNCT01828229

Consequences of Human Inactivity

A study testing female inactivity and hypercaloric diet, inactivity and inactivity and hypercaloric diet in people with Inactivity and Obesity, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Epidemiological studies as well as both longitudinal animal and human inactivity studies indicate that low physical activity is associated with the pathophysiology of type 2 diabetes mellitus (T2DM) and obesity, and recently it has been estimated that physical inactivity (worldwide) causes 7% of the burden of disease… Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Inactivity, Obesity, Type 2 Diabetes
What is being tested?
female inactivity and hypercaloric diet, inactivity and inactivity and hypercaloric diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteDenmark
Study dates
Jan 2009to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Normal physical active
  • Healthy
  • 18-40 y of age
  • Non-smokers

Who cannot join

  • Pregnancy
  • Diabetes in family

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Center og inflammation and metabolism, Rigshospitalet

    Copenhagen

Other trials in Denmark

About this study

Epidemiological studies as well as both longitudinal animal and human inactivity studies indicate that low physical activity is associated with the pathophysiology of type 2 diabetes mellitus (T2DM) and obesity, and recently it has been estimated that physical inactivity (worldwide) causes 7% of the burden of disease related to e.g. T2DM. Physical inactivity, a high energy dietary intake, and T2DM are also associated with dementia, depression, and impaired cognitive function. It is critical that we understand how inactivity alters body composition, glucose and lipid metabolism, and cognitive function, if normal physical activity can prevent these changes, and if there are any differences between sexes.

The present protocol is divided in several in several sub-studies:

  1. To test whether and how a physically inactive lifestyle will influence body composition, glucose and lipid metabolism, and cognitive function.
  2. To test whether normal physical activity can prevent the deleterious effect of a physically inactive lifestyle despite a high-caloric intake.
  3. To test whether the influence of a physically inactive lifestyle combined with a high-caloric intake differs between sexes.
Being tested
female inactivity and hypercaloric diet, inactivity, inactivity and hypercaloric diet, normal activity and hypercaloric diet, inactivity and iso-caloric diet
Keywords
Inactivity, Obesity, Type 2 diabetes, glucose metabolism, Lipid metabolism, Cognitive function
Medical subject headings
Sedentary Behavior, Obesity, Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • female inactivity and hypercaloric dietBehavioural

    female inactivity and hypercaloric diet for 2 weeks

  • inactivityBehavioural

    inactivity for 2 weeks

  • inactivity and hypercaloric dietBehavioural

    inactivity and hypercaloric diet for 2 weeks

  • normal activity and hypercaloric dietBehavioural

    normal activity and hypercaloric diet for 2 weeks

  • inactivity and iso-caloric dietBehavioural

    inactivity and iso-caloric diet for 2 weeks

Study groups in NCT01828229
Study groupRoleWhat they receive
female inactivity and hypercaloric dietExperimentalinactivity and hypercaloric diet in women for two weeks
Receives: Behavioral: female inactivity and hypercaloric diet
inactivityExperimentalInactivity for two weeks
Receives: Behavioral: inactivity
inactivity and hypercaloric dietExperimentalinactivity and hypercaloric diet for two weeks
Receives: Behavioral: inactivity and hypercaloric diet
normal activity and hypercaloric dietExperimentalNormal activity and hypercaloric diet for two weeks
Receives: Behavioral: normal activity and hypercaloric diet
inactivity and iso-caloric dietActive comparatorinactivity and iso-caloric diet for two weeks
Receives: Behavioral: inactivity and iso-caloric diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insulin sensitivity

    Area under the curve of plasma glucose and insulin levels during an oral glucose tolerance test

    Measured: 2 weeks

Secondary outcomes (1)
  1. visceral adiposity

    Amount of visceral fat is determined by MRI scans

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2013 (estimated)
  2. Study startJan 2009
  3. Primary completionJun 2015
  4. Study completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01828229
Sponsor's protocol ID
H-4-2009-082
Status last verified
Jun 2015
First submitted
5 Apr 2013
Last updated
18 Jun 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Olsen RH, Krogh-Madsen R, Thomsen C, Booth FW, Pedersen BK. Metabolic responses to reduced daily steps in healthy nonexercising men. JAMA. 2008 Mar 19;299(11):1261-3. doi: 10.1001/jama.299.11.1259. No abstract available.

    PubMed 18349087
  • Krogh-Madsen R, Thyfault JP, Broholm C, Mortensen OH, Olsen RH, Mounier R, Plomgaard P, van Hall G, Booth FW, Pedersen BK. A 2-wk reduction of ambulatory activity attenuates peripheral insulin sensitivity. J Appl Physiol (1985). 2010 May;108(5):1034-40. doi: 10.1152/japplphysiol.00977.2009. Epub 2009 Dec 31.

    PubMed 20044474
  • Knudsen SH, Hansen LS, Pedersen M, Dejgaard T, Hansen J, Hall GV, Thomsen C, Solomon TP, Pedersen BK, Krogh-Madsen R. Changes in insulin sensitivity precede changes in body composition during 14 days of step reduction combined with overfeeding in healthy young men. J Appl Physiol (1985). 2012 Jul;113(1):7-15. doi: 10.1152/japplphysiol.00189.2011. Epub 2012 May 3.

    PubMed 22556394

Questions about this trial

What is this clinical trial studying?

A study testing female inactivity and hypercaloric diet, inactivity and inactivity and hypercaloric diet in people with Inactivity and Obesity, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insulin sensitivity (time frame: 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01828229, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in